Wed.Dec 07, 2022

article thumbnail

Traditional HTAs keep diverse patients out of the conversation

PhRMA

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important decisions about patient access to health care based on their determination of the value of new tests and treatments.

217
217
article thumbnail

Examining HPV Vaccine Uptake for Adolescents During the Pandemic

Drug Topics

Recent research looks at how the pandemic impacted the uptake of the human papillomavirus vaccine, which has traditionally lagged behind other pediatric vaccine rates.

Vaccines 186
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is Pharmacy Right For You?

Pharmacy Is Right For Me

With college application deadlines looming, you might wonder what the right career path can look like. Have you considered pharmacy? Pharmacy offers countless career options , with pharmacists practicing in pharmacies, health systems, labs, government agencies, corporations, and so much more! Check out our latest video and find out if pharmacy is right for you!

130
130
article thumbnail

Pediatric Vaccine Education Can Improve Pharmacist Knowledge, Confidence

Drug Topics

Not every pharmacist may feel comfortable administering vaccines to children, but education could help.

Vaccines 220
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Cancer patients endure an overlooked financial burden: hospital parking fees

STAT

For many patients, one of the most antagonizing parts of a hospital visit is paying for parking. Those parking fees aren’t just an annoyance for the sick and injured, according to a new paper in the Journal of Medical Imaging and Radiation Sciences. The charges are actually eating into their financial well-being, particularly for people who have cancer and have to make frequent visits to the hospital for treatments like radiation and chemotherapy.

Hospitals 133
article thumbnail

Assessing Pharmacist Comfort in Recommending OTC Medications for Pregnant Patients

Drug Topics

Knowledge gaps can make OTC medication recommendations for this population a challenge.

232
232

More Trending

article thumbnail

As Direct-to-Consumer Companies Grow in Popularity, Their Efficacy is Questioned

Drug Topics

Direct-to-consumer companies attract attention on social media, but are they as effective as traditional healthcare services?

186
186
article thumbnail

Investigation launched into alleged animal welfare violations at Neuralink

pharmaphorum

Elon Musk’s brain computer interface (BCI) company Neuralink is being investigated by law enforcement authorities in the US amid allegations of animal welfare violations in its testing facilities. Neuralink’s BCI is intended to treat conditions like blindness and spinal cord injury, as well as provide a way to interact with digital devices using the brain and, according to Musk, is on the brink of moving into the human testing stage.

article thumbnail

Research Praises Shingles Vaccine Efficacy

Drug Topics

The shingles vaccine appears to confer long-term immunity, according to research.

Vaccines 226
article thumbnail

What FDA’s Newest Gene Therapy Approval Tells Us About Durability: How Long is Long Enough?

The FDA Law Blog

By Mark A. Tobolowsky & James E. Valentine — On November 22, 2022, FDA approved CSL Behring’s BLA for Hemgenix (etranacogene dezaparvovec), an AAV-based gene therapy for the treatment of adults with Hemophilia B who currently use Factor IX prophylaxis therapy, have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes.

FDA 119
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Pharmacist Involvement Has Positive Impact on Patients Receiving Gender Affirming Care

Drug Topics

Pharmacists can optimize medication adherence and serve as an additional touchpoint for patients during treatment.

187
187
article thumbnail

FDA to Evaluate Zuranolone for Major Depressive Disorder, Postpartum Depression

Pharmacy Times

Zuranolone is a rapid-acting, once-daily, 14-day oral short course therapy for adult patients with major depressive disorder and postpartum depression.

FDA 122
article thumbnail

Cost Savings Associated With Therapeutic Exchange of Stimulant Medications

Drug Topics

Cost savings were not associated with an increase in adverse drug events.

187
187
article thumbnail

Eli Lilly tightens access to diabetes drug, frustrating some people with obesity

STAT

Touted by celebrities, raved about by TikTok users and advertised by med spas, a new class of drugs for treating diabetes and obesity has exploded in popularity for its weight-loss effects, leading to rippling shortages across several of the medications. Amid the surge in demand, Eli Lilly and pharmacies have started to tighten access to the latest of this type of drug, tirzepatide, focusing on giving it to people with type 2 diabetes, the only population it’s authorized for so far.

116
116
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Out-of-Pocket Costs Impact Medication Access for Some Medicare Beneficiaries With Schizophrenia

Drug Topics

Low-income subsidies can eliminate much of the out-of-pocket costs that patients must pay.

154
154
article thumbnail

Opinion: Deferral of primary care signals a troubled future for Americans’ health

STAT

Americans may be returning to their pre-pandemic habits , but most have not returned to their primary care doctors. Primary care visits are down 10.3% on average across U.S. cities relative to pre-pandemic levels. That, combined with more people with chronic diseases like diabetes, obesity, and cancer, and accelerating health care costs as inflation soars, signal a troubled future for the health of Americans and the U.S.

116
116
article thumbnail

Survey Finds Many US Adults Were Not Prepared for Severity of Current Flu Season

Pharmacy Times

The current flu hospitalization rate is the highest observed this early in a flu season in over a decade.

Hospitals 139
article thumbnail

STAT+: Prometheus’ inflammatory bowel drug succeeds in two mid-stage trials

STAT

An investigative medicine from Prometheus Biosciences met its goals in a pair of Phase 2 studies enrolling patients with inflammatory bowel disease, setting the stage for pivotal trials and nearly doubling the company’s stock price. In an ulcerative colitis study enrolling about 130 volunteers, Prometheus’ drug helped nearly 27% of patients reach clinical remission, defined as an absence of serious symptoms, compared to 1.5% for the placebo group, the company said.

Labelling 108
article thumbnail

World Genomics Evaluation in Clinical Trials Sparks Worldwide Interest

Pharmacy Times

Breast cancer expert joined a panel to discuss aromatase inhibitors at the San Antonio Breast Cancer Symposium (SABCS) on December 6, 2022.

118
118
article thumbnail

STAT+: FDA scolds company that raised red flags over impurities in many widely used medicines

STAT

Two years after an independent laboratory began pushing the Food and Drug Administration to analyze various medicines for traces of carcinogens, the agency sent inspectors to the company and cited it for failing to comply with federal law. In a Dec. 5 letter , the agency wrote Valisure that its online pharmacy failed to take several basic steps to ensure that suspect or illegitimate medicines were investigated and that distributors were alerted.

FDA 105
article thumbnail

Health Canada approves Novavax’s Covid-19 vaccine for adolescents

Pharmaceutical Technology

Health Canada has granted approval for a supplement to a New Drug Submission (sNDS) of Novavax ’s Covid-19 vaccine (Recombinant protein, Adjuvanted), Nuvaxovid (NVX-CoV2373), for use in adolescents aged 12 to 17 years. The vaccine is indicated to be administered as a primary regimen comprising two doses for active immunisation to prevent Covid-19 in adolescents of this age group.

Vaccines 105
article thumbnail

How eligible patient numbers affect price of rare disease drugs in France

pharmaphorum

Having recently assessed the relationship between drug price and prevalence of non-oncology rare diseases, CRA’s Life Sciences Practice team explores in greater depth the situation for these orphan drugs in France in this final article of a three-part series. Pricing and market access in France operate on a dual system, under which health technology assessments (HTAs) are conducted separately from pricing negotiations.

103
103
article thumbnail

STAT+: In ‘landmark’ study, cell therapy exceeds expectations in melanoma patients

STAT

When tumors like melanoma form, the immune system mobilizes for war. White blood cells called lymphocytes rush to assault the tumor — but cancer has ways of disabling the immune system. Once the immune cells penetrate the area in and around the tumor, they can be caught in chemical snares that render them inert or exhausted, so they cease working.

article thumbnail

Align reimbursement to expanded role of pharmacists

Drug Store News

The industry is moving to more value-based reimbursement with community pharmacy playing an increasingly important role.

article thumbnail

STAT+: Could Vertex’s cystic fibrosis medicines hold a clue to treating deadly pneumonia?

STAT

About a year ago, a grad student came running up to Wolfgang Kuebler, looking all excited: The mice , he said — well, to be honest, the mice didn’t look great, but they looked a heck of a lot better than they did before. Not long before, Kuebler’s students at The Charité in Berlin had anesthetized mice and dropped a bit of Streptococcus pneumoniae down their throats, just enough to sicken but not kill.

100
100
article thumbnail

2023 BCGP Exam Changes

Med Ed 101

Are you looking to become a Board Certified Geriatric Pharmacist in 2023? You’ll want to pay attention to this post. We have a rundown of all the 2023 BCGP exam changes including changes to the content outline and what it means for your study preparations. First and foremost, the content outline is remaining the same […]. The post 2023 BCGP Exam Changes appeared first on Med Ed 101.

98
article thumbnail

What were the most popular drugs in these 50 U.S. cities in 2022?

The Checkup by Singlecare

Sometimes, your head aches or you feel a twinge in your knee, but you don’t have time to do much about it. You figure that all you really need to feel better again and keep moving is to take some ibuprofen. . If you found yourself reaching for this popular non-steroidal anti-inflammatory drug (NSAID) to treat minor aches, pains, and fevers this past year, you weren’t alone.

Dosage 98
article thumbnail

UK pharmacists report shortages of strep A antibiotics

The Guardian - Pharmaceutical Industry

Health secretary says government ‘not aware’ of issue but some independent outlets say stocks running low UK politics live – latest news updates Pharmacists are reporting UK-wide shortages of the antibiotics used to treat strep A, despite the health secretary insisting that the government is “not aware” of a problem. Demand for penicillin and amoxicillin has increased in recent days as the number of cases of strep A has risen among children in schools.

article thumbnail

Unsupported Drug Price Increases Added $805 Million in Costs

Drug Topics

Seven of the 10 top selling drugs with high price increases lack the clinical evidence to justify those increases.

98
article thumbnail

Woman of the Week: Simcha Therapeutics’ Beatrice McQueen

PharmaVoice

From sea sponges to cytokines, the chief operating officer’s career has come full circle as she pursues a new approach to treating cancer via the immune system.

article thumbnail

Some Supplements Found to Benefit Cardiovascular Health, Others May Have Negative Impact

Pharmacy Times

Omega-3 fatty acids among the micronutrients found to provide a benefit to cardiovascular health.

123
123
article thumbnail

Upcoding isn't solely to blame for spike in 'high-intensity' ED billing, researchers say

Fierce Healthcare

Upcoding isn't solely to blame for spike in 'high-intensity' ED billing, researchers say. dmuoio. Wed, 12/07/2022 - 15:39.

116
116
article thumbnail

Jardiance® improves blood sugar control in type 2 diabetes

European Pharmaceutical Review

Jardiance ® ( empagliflozin ) reduced HbA1c (a marker of average blood sugar) by 0.84 percent when used alongside other baseline treatments (diet, exercise, metformin and/or insulin), compared with placebo in a Phase III clinical trial of children and adolescents aged 10-17 years with type 2 diabetes. The results indicated HbA1c reduced to these levels at week 26 (95 percent confidence interval (CI) –1.50 to –0.19; P=0.012).

article thumbnail

The Future of Ophthalmology Depends Next-Gen Ecosystems: Q&A with Seba Leoni, Global Head & General Manager, Alcon Vision Suite

Fierce Healthcare

The Future of Ophthalmology Depends Next-Gen Ecosystems: Q&A with Seba Leoni, Global Head & General Manager, Alcon Vision Suite. mteefey. Wed, 12/07/2022 - 17:47.

98